Myocardial perfusion scan is a cardiac diagnostic procedure using nuclear medicines so as to analyze cardiac functions and reveal any problems related to cardiac muscles. Myocardial perfusion scan helps to evaluate various cardiac diseases or dysfunctions ranging from coronary vessel block up to the hypertrophic diseases of heart like the cardiomyopathy or ventricular abnormalities.
Cardiac rehabilitation is a tertiary treatment programs conducted for the patients who have undergone cardiac surgeries especially bypass grafting or cardiac stenting or angioplasty. It is a program that is medically supervised in order to help the cardiac patients recover faster and improve their physical, social, mental, and overall health. It's aim is to stabilize the condition of the patient or slowly reverse the progressiveness of the heart disease, and thus minimize the risk of another cardiac problem or the death of the patient.
Amiodarone is an anti-arrhythmic medication which aids patients suffering from life-threatening ventricular and supraventricular rhythm disorders. This medication is applied in the case of ventricular tachycardia or ventricular fibrillation. Although amiodarone was discovered in 1961, it wasn't approved for medical applications until 1985, in the United States. This delay in approval is a testament to the fact that amiodarone is the strangest anti-arrythmic drug ever developed even though it is the most effective.
India is fast becoming a destination for Heart Treatment. Open-heart surgery costs in India are low when compared to the West. In fact, they are only a tenth of the cost at comparable hospitals in Europe and the USA. In the UK the cost of heart surgery is £30,000 and up-to $60,000 in the USA depending on the nature of the operation. In India’s best hospitals, the cost could be between $3,000 and $10,000 for the same surgery. The success rates in India’s top hospitals for heart surgery are an average of 98.50%. This is on par with the leading cardiac centers in the world.